« Return to News | Awards & Advancement

Duke University and the Wallace H. Coulter Foundation create $20 million endowment

Thursday, April 21, 2011 12:41 PM

Duke University and the Wallace H. Coulter Foundation have created a $20 million endowment to foster a research collaboration between bioengineers and clinicians with the goal of developing new technologies to improve patient care.

Ten million dollars from the Coulter Foundation will fund the partnership along with additional investments from Duke and the Fitzpatrick Foundation, bringing the total to $20 million.

Elias Caro, vice president of technology development at the foundation, said, "As a member of the Coulter program, Duke adopted the Coulter Process, an industry-like development process, that includes a thorough commercialization analysis which assesses intellectual property, FDA requirements, reimbursement, critical milestones and clinical adoption. This attracted follow-on funding from venture capital and biomedical companies."  

In 2005, the Coulter Foundation picked Duke to move university biomedical engineering projects into commercial products and clinical practices.  Since then, 19 Duke projects have been funded.  Projects surround clinical research areas such as detecting prostate cancer and esophageal pre-cancerous lesions, treating hemophilia and controlling urinary function for paraplegics.

Three startup companies, many licensing agreements, more than $35 million in venture capital and investments, and another $47 million in federal, state or foundation grants have resulted from this partnership. This new endowment will allow for the continued support of promising projects at Duke, said biomedical engineering department chair George Truskey.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

 

Copyright © 1995-2013 CenterWatch.